Background. Following stroke, a growth-promoting response resulting in heightened neuroplasticity occurs during the early subacute stages of recovery, a period during which the brain may be more responsive to therapeutical interventions. Given its central role in regulating neuroplastic processes and brain repair in animal models, brain-derived neurotrophic factor (BDNF) has been investigated as a potential biomarker for stroke recovery in humans, with interventions upregulating it holding therapeutical potential. Cardiovascular exercise (CE) has been recommended for stroke rehabilitation, partly due to its potential to induce neural adaptations, including upregulation of BDNF.

Objectives. To examine the effects of CE on BDNF in individuals at early subacute stages of recovery.

Methods. 76 participants within 3 months of first-ever ischemic stroke were randomly assigned to eight weeks of either CE plus standard care or standard care alone. To measure the chronic and acute responses to exercise in serum BDNF levels, blood samples were collected before and immediately after a graded exercise test conducted at baseline, four and eight weeks. The potential role of the BDNF Val66Met polymorphism in modulating the BDNF response to CE was also explored.

Results. Despite significant increases in cardiorespiratory fitness, CE did not induce any significant chronic or acute changes in BDNF concentration. Similarly, the BDNF response to CE was not modulated by the Val66Met polymorphism or associated with changes in cardiorespiratory fitness and clinical outcomes.

Conclusions. These findings indicate limited effects of CE in modulating circulating BDNF in subacute stages of stroke recovery.

Trial Registration: Exercise and Genotype in Sub-acute Stroke: https://clinicaltrials.gov/study/NCT05076747

The authors have declared no competing interest.

NCT05076747

This study is funded by a Grant from The Canadian Partnership for Stroke Recovery (CPSR). Lynden Rodrigues is supported by a Doctoral Scholarship from the Fonds Recherche Sante Quebec (FRQS). Ziv Gan-Or is supported by a Salary Award (Junior II) from Fonds de Recherche Sante Quebec (FRQS). Janice Eng is supported by the Canada Research Chairs program. Marc Roig is supported by a Salary Award (Junior II) from Fonds de Recherche Sante Quebec (FRQS).

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of Centre de Recherche de Readaptation du Montreal (CRIR-1265-0817) gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes